|
🐜
|
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn
16 auth.
Danlin Yang,
C. Giragossian,
S. Castellano,
M. Lasaro,
Haiguang Xiao,
H. Saraf,
Cynthia Hess Kenny,
I. Rybina,
Zhong-Fu Huang,
J. Ahlberg,
...
Tammy Bigwarfe,
Maria Myzithras,
Erica Waltz,
Simon Roberts,
Rachel Kroe-Barrett,
Sanjaya Singh
|
4 |
2017 |
4
🐜
|
|
🐜
|
An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases.
18 auth.
Helen Haixia Wu,
K. Ralph,
Eliud Sepuldeva,
G. Hansen,
Hua Li,
Zhong-Fu Huang,
Dongmei Liu,
Michael Dziegelewski,
J. Ahlberg,
L. Frego,
...
S. Fogal,
Susan van Tongeren,
C. Grimaldi,
Tobias Litzenberger,
D. Presky,
Sanjaya Singh,
S. Brodeur,
Rachel Kroe-Barrett
|
2 |
2021 |
2
🐜
|
|
🐜
|
An adapted consensus protein design strategy for identifying globally optimal biotherapeutics
25 auth.
Yanyun Liu,
Kenny Tsang,
M. Mays,
G. Hansen,
Jeff C. Chiecko,
Maureen Crames,
Yangjie Wei,
Weijie Zhou,
Chase Fredrick,
James Hu,
Dongmei Liu,
Douglas Gebhard,
Zhong-Fu Huang,
A. Datar,
Anthony Kronkaitis,
...
K. Gueneva-Boucheva,
Daniel Seeliger,
Fei Han,
S. Sen,
S. Kasturirangan,
J. Scheer,
A. Nixon,
T. Panavas,
M. S. Marlow,
Sandeep Kumar
|
1 |
2022 |
1
🐜
|
|
🐜
|
Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability
9 auth.
Pankaj Gupta,
A. Horspool,
Goral Trivedi,
Gina Moretti,
A. Datar,
Zhong-Fu Huang,
...
Jeffrey Chiecko,
C. H. Kenny,
Michael S. Marlow
|
0 |
2023 |
0
🐜
|
